Marimed Inc (OTCMKTS:MRMD) has signed an exclusive distribution accord with Ilo Vapor. As per the terms of the deal, Marimed will distribute DabTab brand dablets to all the cannabis dispensaries located in Maryland. The company will introduce the dablets to dispensaries in Delaware, Massachusetts, and Rhode Island later this spring.

DabTab Brand Dablet

Each DabTab Dablet consists of 50 mg of cannabis concentrate. Introduced in November 2018 in Las Vegas at MJBizCon Conference, it offers a new way for customers to enjoy cannabis concentrate vapor. The clean and precision dosed DabTab provides all conventional dabbing effects. The branded dabtab are available in hydrid, Indica, and Sativa varieties in packs of 1g, 05 g, 10 and 20 g. The company distributes premium concentrate infused DabTabs in Maryland.

Cannabis Concentrates Sales

The sales of cannabis concentrates are expected to reach $8.5 billion in 2022 from $3 billion in 2018. Cannabis concentrates offer a healthier choice for consumers as they need not inhale smoke. Bob Fireman, Chief Executive Officer of Marimed said Ilo Vapor is well known for innovation in the cannabis industry. The revolutionary DabTab brand dablet is expected to promote growth among women, medical users and seniors. Other features for accelerated growth include smokeless, precise dosage, and convenience.

Co-founder and President of ilo Vapor, Michael Lindars said the company’s products are developed to offer reliability, convenience, and true vaporization. The company is pleased to enter a pact with Marimed.

Following the robust demand for cannabis products, the market for cannabis is expected to become a multibillion dollar house. Companies like Marimed are racing in with hemp derived CBD products to capitalize on this trend. The company pumped in $30 million in GenCanna, a Kentucky based company.

Marimed to showcase products

Marimed will showcase its product range at a NECANN Conference during March 22 and 24 2019 in Boston. The company is committed to deliver high quality cannabis and hemp products to maintain wellness and health of consumers. Its revenues have increased by 98% year on year to reach $3.4 million in Q3 2018. The company’s success is attributed to professional management and success of the licensed cannabis clients.